Related by context. All words. (Click for frequent words.) 77 Gleevec resistant 75 K ras mutations 75 FLT3 74 imatinib Gleevec 73 EGFR tyrosine kinase inhibitors 73 myelofibrosis polycythemia vera 73 gefitinib Iressa 73 epithelial tumors 72 imatinib resistant 72 Epidermal Growth Factor Receptor 72 BRAF V#E mutation 72 T#I mutation 72 replicon 72 BCR ABL 71 BRAF mutation 71 receptor tyrosine kinase inhibitor 71 TTR gene 71 chimeric monoclonal antibody 71 hypereosinophilic syndrome 71 EGFR TKI 71 K RAS 71 erlotinib Tarceva 71 T#I mutant 71 UGT#A# 71 selective modulator 71 Immunohistochemical analysis 70 Xanafide 70 androgen receptor AR 70 CYT# potent vascular disrupting 70 EGFR inhibitors 70 Onconase 70 thalidomide Thalomid 70 trastuzumab Herceptin ® 70 MAGE A3 ASCI 70 IGF IR 70 EGF receptor 70 HER2/neu 70 carcinoembryonic antigen 70 colon carcinoma 70 Clusterin 70 E#F# 70 KRAS mutation 70 c MET 69 imatinib Gleevec ® 69 KRAS mutations 69 Epratuzumab 69 PTPN# 69 cytotoxin 69 Fc gamma receptor 69 BRAF mutations 69 cyclin E 69 alpha interferon 69 GNAQ 69 virulence genes 69 Omacetaxine 69 Protein Kinase C 69 cytostatic 69 antibody MAb 69 chemokine receptor 69 pan HDAC inhibitor 69 erlotinib Tarceva ® 69 syngeneic 69 Dasatinib 69 Leukemias 69 Bcr Abl 69 EGFr 69 NPM1 69 DFMO 69 targeting CD# 69 RAV# 69 hepatoma 69 leukemia CLL 69 Zolinza 69 Janus kinase 69 EGFRvIII 69 glutamic acid decarboxylase 69 Tumor Necrosis Factor 69 trans retinoic acid 69 mutated K ras 69 ABCB1 69 dasatinib Sprycel ® 69 alpha#beta# integrin 69 NS#/#A protease 69 KRAS gene 69 CDK inhibitor 69 DHFR 69 vimentin 69 oral prodrug 69 cisplatin resistant 68 dasatinib 68 fluoropyrimidine 68 Myelodysplastic Syndrome MDS 68 anti CD3 68 galiximab 68 Ceflatonin 68 Nedd4 68 nucleoside analogues 68 HER2 receptor 68 cilengitide 68 dasatinib Sprycel 68 protein tyrosine phosphatase 1B 68 Her2/neu 68 mTOR mammalian target 68 anti angiogenic agent 68 recurrent glioblastoma multiforme 68 proteasome inhibitor 68 FUS1 68 HER2 overexpression 68 ZOLINZA 68 gastrointestinal stromal tumors GIST 68 tigecycline 68 KRAS oncogene 68 TNFα 68 huC# DM4 68 Trastuzumab 68 antisense oligonucleotide 68 topoisomerase 68 M#V mutation 68 cMET 68 VEGF receptor 68 Upregulation 68 endothelin receptor 68 histone deacetylases 68 busulfan 68 Symadex 68 PKC# 68 Aurora kinase 68 mutant BRAF 68 vemurafenib 68 colorectal carcinoma 68 B Raf 68 leukemia AML 68 Tyrosine Kinase Inhibitor 68 GPNMB 68 selectively inhibited 68 ERBB2 68 metastatic malignant 68 Bevacizumab 68 Enzastaurin 68 TRAIL induced apoptosis 68 antiangiogenic therapy 68 alefacept 68 ATL# [001] 68 alkaline phosphatase ALP 68 mda 7 68 tipranavir ritonavir 67 Fas ligand 67 CRTH2 67 humanized antibody 67 anthracycline chemotherapy 67 nilotinib 67 constitutively active 67 MAPK pathway 67 K ras 67 pathophysiological effects 67 metastatic malignant melanoma 67 IgG1 67 sunitinib Sutent ® 67 HLA B# 67 M2 subunit 67 PEGylated Fab fragment 67 p# mitogen activated 67 TOP2A 67 Temsirolimus 67 XmAb# 67 BCR ABL1 67 vWF 67 tumorigenicity 67 adipogenic 67 Kahalalide F 67 imatinib resistance 67 phosphate S1P 67 paclitaxel Taxol 67 luteinizing hormone releasing 67 NKG2D 67 fosbretabulin 67 Granulocyte Colony Stimulating Factor 67 JAK2 V#F 67 IGF 1R 67 Factor Receptor 67 hTERT 67 AGTR1 67 myeloproliferative 67 thyroglobulin 67 ovarian carcinoma 67 glycopeptide 67 isotype 67 nutlin 3a 67 ENMD # 67 Akt activation 67 CD# CD# 67 activating mutations 67 cell lymphoma CTCL 67 FGFR1 67 immunotoxin 67 EGFR mutations 67 Azacitidine 67 p# biomarker 67 imatinib therapy 67 interleukin IL -# 67 BRAF V#E 67 liposomal formulation 67 5alpha reductase 67 flavopiridol 67 Vidaza azacitidine 67 CYP #D# 67 thrombin receptor 67 multidrug resistance 67 A3 adenosine receptor 67 HLA DR 67 mTOR inhibitors 67 engineered RAP peptides 67 miR #a [001] 67 orally administered inhibitor 67 Trp p8 67 ADAMTS# 67 protein tyrosine phosphatases 67 potent inhibition 67 NPM1 mutation 67 TKIs 67 cetuximab Erbitux R 67 antisense inhibition 67 herpesviruses 67 Treg cell 67 IgG1 antibody 67 GSTP1 67 JAK2 enzyme 67 cathepsins 67 survivin 67 Vidaza ® 67 Pralatrexate 67 TrkA 67 E. faecalis 67 Bortezomib 67 XYOTAX TM 67 HLA DR4 67 CCX# 67 activin 67 HCV protease 67 NSCLC tumors 67 5HT 67 VEGFR1 67 NS4A 67 Mucosal 67 VKORC1 67 Haptoglobin 67 Decitabine 67 tyrosine kinase inhibitor 67 Chemokine Receptor 67 Interferon gamma 67 HCV replicon 67 breast cancer subtypes 67 LRP5 67 thymidine 67 bleomycin 67 gemcitabine carboplatin 67 poly ADP ribose polymerase 67 EGFR receptor 67 Epstein Barr virus EBV 67 proto oncogene 67 soluble tumor necrosis 67 N. gonorrhoeae 67 Estrogen Receptor 67 sodium glucose cotransporter 67 anaplastic lymphoma kinase ALK 67 interferon IFN 67 HER3 67 Cytotoxic T 67 Bafetinib 67 KRAS mutant 67 trabectedin 67 FGFR4 67 eIF 4E 67 alkylating agent 67 Imatinib 67 Fulvestrant 67 antisense inhibitors 67 antiproliferative effects 67 GW# [003] 67 Taxol ® 67 TNF α 67 IGFBP2 67 T#M mutation 67 glycosylated 67 isotypes 67 chronic myeloid leukemia CML 67 tyrosine kinase inhibitors TKIs 67 huN# DM1 67 cetuximab Erbitux ® 66 decitabine 66 kinase inhibition 66 HLA DR4 immune 66 LHRH 66 ON #.Na 66 Tarvacin 66 thymidylate synthase 66 mRCC 66 PARP inhibition 66 IL#B 66 p# MAPK 66 #HT#A 66 N Myc 66 Virulizin ® 66 EpCAM 66 thrombopoietin 66 Elotuzumab 66 thymidylate synthase TS 66 polycythemia vera PV 66 endogenous ligands 66 IFN α 66 IFN γ 66 IgG antibody 66 CD# monoclonal antibody 66 5 HT6 receptor 66 Aflibercept 66 gastrointestinal stromal tumors 66 inhibits protein synthesis 66 chronic eosinophilic leukemia 66 soluble receptor 66 gastrointestinal stromal tumors GISTs 66 missense mutation 66 MDR1 66 HER-2/neu 66 androgen independent 66 γ secretase 66 Tyrima 66 HDACi 66 ceftazidime 66 Pemetrexed 66 alpha folate receptor 66 AMACR 66 imatinib mesylate 66 Sapacitabine 66 pancreatic adenocarcinoma 66 WT1 66 Alkaline Phosphatase 66 Cytochrome P# 66 humanized anti 66 TLE3 66 T#M 66 miR #a [002] 66 Oritavancin 66 ADAM# 66 effector function 66 Secretase 66 Aplidin 66 rhIL 7 66 synthetic analogues 66 breast carcinomas 66 Degarelix 66 JAK inhibitors 66 Velcade bortezomib 66 docetaxel Taxotere ® 66 VEGF inhibitors 66 CDK4 66 Interferon alpha 66 TNFalpha 66 EGFR HER2 66 diagnostic biomarker 66 transthyretin amyloidosis 66 Factor VEGF 66 antisense oligonucleotides 66 myeloma cells 66 microtubule inhibitor 66 hENT1 66 radezolid 66 antibody trastuzumab 66 MSH2 66 annexin V 66 mCRC patients 66 dihydrofolate reductase 66 EGFR protein 66 IAP inhibitor 66 prostate carcinoma 66 HBeAg negative 66 humanized monoclonal antibodies 66 S/GSK# 66 CD# expressing 66 Î ² 66 FGFR2 66 c MYC 66 ADPKD 66 azacytidine 66 HIF 1alpha 66 basal cell carcinoma BCC 66 familial ALS 66 splice variants 66 plasma kallikrein 66 cAMP signaling 66 HAAH 66 CD#b 66 GBM tumors 66 Campath alemtuzumab 66 RRM1 66 haematologic 66 ERK1 2 66 lymphocytosis 66 myeloproliferative diseases 66 ELISPOT assay 66 oncoprotein 66 myeloid 66 MGd 66 missense mutations 66 D aspartate NMDA receptor 66 metastatic colorectal 66 cytolytic 66 Aurora Kinase 66 Bcr Abl inhibitors 66 replicase 66 MDM2 66 Mutational 66 EphA2 66 NRTI resistance 66 HuLuc# 66 Dalbavancin 66 K#N 66 GLUT1 66 MetMAb 66 somatostatin analogue 66 fulvestrant 66 IL #E 66 HLA DR2 66 vinca alkaloid 66 GRN# 66 Traficet EN 66 Bosutinib 66 MAb 66 mapatumumab 66 denileukin diftitox 66 leukemic stem cells 66 somatostatin 66 neuroblastoma tumors 66 Squamous 66 Recombinant Human 66 PC# cells 66 factor Xa 66 IGFBP 3 66 IFNa 66 bispecific 66 histone deacetylase HDAC inhibitor 66 castrate resistant 66 CYP3A 66 LymphoStat B belimumab 66 tumor antigen 66 Flt3 66 generation antisense inhibitor 66 HER2 expression 66 superficial bladder cancer 66 pancreatic carcinoma 66 relapsed leukemia 66 CD# mAb 66 LRAT 66 EGFR mutation 66 selective kinase inhibitor 66 investigational humanized monoclonal antibody 66 K ras gene 66 5 HT1A 66 AEG# 66 HGS ETR2 66 Lenalidomide 66 HLA DRB1 * 66 GPx 66 anaplastic lymphoma kinase 66 OHR/AVR# 66 tumor xenograft models 66 rhIGFBP 3 66 adenoviral 66 Factor VIIa 66 TIMP 1 66 neuropilin 66 annexin 66 antibody fragment 66 MAP kinase 66 Noxafil 65 lymphoid cells 65 TLR9 agonists 65 proteolytic cleavage 65 xenograft tumors 65 vascular disrupting agents 65 Anticalins ® 65 MET amplification 65 catenin 65 bevacizumab Avastin ® 65 preclinically 65 EGFR antibodies 65 bcl 2 65 mutated KRAS 65 serine threonine kinase 65 Kinoid 65 BCR ABL protein 65 unmutated 65 papillary renal cell carcinoma 65 meropenem 65 tryptase 65 prostate cancer CaP 65 TGF ß 65 p# deficient 65 huntingtin gene 65 glioma cells 65 Lymphocytic 65 Lenocta 65 HepG2 cells 65 immune modulating 65 Irinotecan 65 seliciclib 65 oxysterols 65 chemoresistance 65 PAR1 65 CXCR4 65 dermatophytes 65 protein kinase inhibitor 65 RhuDex R 65 NOD mice 65 PI3K Akt 65 S. pyogenes 65 nucleoside analog 65 cTnI 65 uricase 65 gastrointestinal stromal tumor GIST 65 Cethromycin 65 NPM1 mutations 65 HBV genotypes 65 malignant ascites 65 Annexin V 65 enzastaurin 65 Gefitinib 65 tyrosine kinase inhibitors 65 somatostatin receptors 65 tyrosine kinase receptor 65 Olaparib 65 CYT# QbG# 65 histone deacetylase HDAC 65 Soft Tissue Sarcoma 65 ALN TTR 65 chronic lymphocytic leukemia CLL 65 dexpramipexole 65 Vorinostat 65 Diffuse Large B 65 atypical hemolytic uremic syndrome 65 tyrosine phosphorylation 65 CLL cells 65 Wnt signaling pathway 65 CD# antibody [001] 65 tafamidis 65 BRAF gene 65 demethylating agent 65 EGFR pathway 65 haematopoietic 65 Vidofludimus 65 Nilotinib 65 rifamycins 65 tipifarnib 65 Omacetaxine mepesuccinate 65 refractory chronic lymphocytic 65 mineralocorticoid receptor 65 ALK inhibitor 65 reverse transcriptase inhibitors 65 CD#c 65 uPAR 65 PDGFR 65 AT1R 65 histological subtype 65 multikinase inhibitor 65 isoenzyme 65 Erlotinib 65 Cathepsin B 65 Pharmacokinetics PK 65 SIRT2 65 Tarceva TM 65 glycogen synthase kinase 65 immunoglobulin G 65 Epstein Barr Virus EBV 65 DLC1 65 SMN1 65 CYP#A# CYP#D# 65 chemosensitivity 65 RhuDex ® 65 anti CD3 antibody 65 HQK 65 potent inhibitory 65 SSc 65 PLX# 65 prostanoid 65 multiple myeloma MM 65 CCR5 antagonist 65 serine protease 65 CTLs 65 multitargeted 65 NKX#.# 65 complete cytogenetic response 65 idarubicin 65 hypermethylated 65 CANCIDAS 65 FGFR3 65 mAb 65 systemic anaplastic large 65 Sudhir Agrawal D.Phil 65 relapsed MM 65 hepatocellular carcinomas 65 OvaRex MAb 65 clusterin 65 thiopurine drugs 65 glucocorticoid receptor 65 mitogen activated protein kinase 65 CD4 + CD# 65 tumoral 65 NAbs 65 PPARγ 65 Pegylated 65 siRNA mediated 65 cytokine signaling 65 MLH1 65 cytidine 65 genotypic resistance 65 YONDELIS 65 myeloproliferative disorders 65 TACI Ig 65 Crizotinib 65 Dacogen decitabine 65 bortezomib Velcade 65 CD# antibodies 65 oral JAK1 65 retinoic acid receptor 65 constitutively expressed 65 EGF receptors 65 peptide antigens 65 ganciclovir 65 tubulin inhibitor 65 MMP# 65 V#F mutation 65 transgene expression 65 PLA2 65 receptor blocker 65 melatonin receptor 65 beta 1a 65 tubulin polymerization 65 eIF4E 65 β2 65 K#R [002] 65 panitumumab Vectibix 65 Adjuvant chemotherapy 65 castration resistant prostate cancer 65 pDCs 65 orthotopic model 65 BAL# [002] 65 Cloretazine 65 chemically modified siRNA 65 mGlu2 3 65 GHRH 65 Janus Kinase 65 neuronal nicotinic receptor NNR 65 p# activation 65 PDGF receptor 65 mediated inhibition 65 ErbB2 65 immune modulatory 65 SERMs 65 glycosyltransferase 65 clade B 65 JAK inhibitor 65 imatinib mesylate Gleevec 65 apoptosis proteins 65 Talabostat 65 Cyclin E 65 HBeAg positive 65 caveolin 1 65 AAG geldanamycin analog 65 pegylated 65 granzyme B 65 oncoproteins 65 Aviptadil 65 BRAF protein 65 Kinase Inhibitor 65 homodimers 65 castrate resistant prostate cancer 65 Androgen Receptor 65 immunohistochemical staining 65 Bcr Abl mutations 65 demyelinating 65 Oncogenic 65 P#X# receptor 65 immunomodulating 65 Hurthle cell 65 bicalutamide 65 Bezielle 65 Glioblastoma Multiforme 65 mertansine 65 demonstrated antitumor activity 65 pentamidine 65 refractory chronic myeloid 65 alkylating agents 65 nanomolar 65 Cryptococcus neoformans 65 nucleoside analogue 65 humanised monoclonal antibody 65 potent anti angiogenic 65 SOD1 gene 65 antiangiogenic agent 65 idraparinux 65 biliary tract cancer 65 familial amyloidotic polyneuropathy FAP 65 humanized monoclonal antibody 65 LY# [003] 65 beta lactams 65 refractory NSCLC 65 IgG1 monoclonal antibody 65 adrenoceptor 65 PROCHYMAL 65 CYP#C# [002] 65 ABL1 65 PEG IFN 65 antibody mediated 65 extracellular domain 65 renal fibrosis 65 PDGFR alpha 65 xenograft models 65 murine models 65 EGFR mutant 65 5 Fluorouracil 65 GISTs 65 metaglidasen 65 immunostaining 65 inducible nitric oxide synthase 65 caspofungin 65 receptor inhibitor 65 bevacizumab Avastin R 65 immunomodulator 65 tumor suppressor protein 65 BMS # 65 Valortim R 65 trastuzumab Herceptin 65 corticosteroid dexamethasone 65 myelodysplastic myeloproliferative diseases 65 Ocrelizumab 65 hypoxia inducible factor 65 ^ sup #m 65 PTP 1B 65 lactate dehydrogenase LDH 65 LRP6 65 lytic 65 cell mediated cytotoxicity 65 Foxp3 65 castration resistant 65 tumor specific antigen 65 thymoma 65 hedgehog pathway 65 Bleomycin 65 Liposomal 65 EndoTAGTM 1 65 SGS# 65 DEB# 65 EGFR TKIs 65 glucocorticoid receptors 65 CCR1 65 AZT zidovudine Retrovir 65 Fluorouracil 65 selective serotonin 2C receptor 65 PSMA ADC 65 Nucleoside 64 H. influenzae 64 BAL# [001] 64 Virologic 64 hormone refractory 64 HIF 1a 64 MALT lymphoma 64 Cytotoxic 64 Meets Primary Endpoint 64 aT cell 64 PI3K inhibitor 64 pyrimidine 64 MTHFR 64 5 HT4 64 T2DM 64 erythropoietic 64 KIT mutations 64 chemotherapeutic drug 64 NNRTIs 64 Methylnaltrexone 64 serous ovarian cancer 64 NOD mouse 64 MAGE A3 64 IMA# 64 gastric adenocarcinoma 64 chemoresistant 64 polyglutamate 64 GSK3B 64 sorafenib Nexavar 64 targeted radiotherapeutic 64 induce apoptosis 64 immunoregulatory 64 ritonavir boosted 64 B7 H3 64 Elvitegravir 64 fluvastatin 64 Androgen receptor 64 DermaVir 64 eotaxin 64 adriamycin 64 plasmid encoding 64 hypomethylating agents 64 molecularly targeted 64 chloride secretion 64 BRAF inhibitor 64 pegylated liposomal doxorubicin 64 ErbB3 64 Pertuzumab 64 IFN beta 64 H pylori 64 antiangiogenesis 64 mutant KRAS 64 Genentech Rituxan 64 synovial cells 64 NFkB 64 CYP#D# 64 trastuzumab Herceptin R 64 mRNA transcripts 64 Akt3 64 Ceftaroline 64 hematological malignancy 64 metastatic neuroendocrine tumors 64 anti EGFR antibody 64 milatuzumab 64 Panzem 64 complement inhibitor eculizumab 64 FCGR3A 64 anti angiogenic agents 64 SPRYCEL ® 64 STK# [002] 64 FOLFIRI 64 interferon γ 64 schizophrenia CIAS 64 MEK inhibitor 64 Fludarabine 64 Interferon alfa 64 PTP1B 64 kidney urologic 64 ras gene 64 vitro assay 64 ZNF# 64 OXi# 64 Chronic Myeloid Leukemia CML 64 microRNA expression 64 C. difficile toxins 64 BRAF kinase 64 Onrigin 64 hA# 64 ribonuclease 64 Mipomersen 64 neuroregenerative 64 bFGF 64 p# MAP kinase 64 TAp# 64 VIPR2 64 leukemic cells 64 cutaneous T 64 IgA deficiency 64 cyclophosphamide methotrexate 64 retapamulin 64 osteopontin 64 visilizumab 64 Leydig cell 64 bactericidal activity 64 ectopic expression 64 p# mutation 64 TGF β 64 mycophenolate mofetil 64 ATTR CM 64 Papillary 64 P selectin 64 EZN 64 VAPRISOL 64 endoplasmic reticulum stress 64 mutations conferring 64 VEGF inhibitor 64 Gleevec imatinib mesylate 64 c KIT 64 pRb 64 TPMT 64 Rituxan rituximab 64 Sipuleucel T 64 Oncolytic 64 murine model 64 C5aR 64 interferon lambda 64 mutant alleles 64 Teriflunomide 64 HBeAg 64 CGRP 64 XL# inhibits 64 protein tyrosine kinase 64 grade cervical intraepithelial 64 Receptor Antagonists 64 imipenem 64 Progressive Multifocal Leukoencephalopathy 64 CagA 64 Copegus ribavirin 64 Interferon Beta 64 Cytogenetic 64 vismodegib 64 ara C 64 pharmacodynamic biomarkers 64 PCa 64 VA# [002] 64 pro apoptotic 64 virotherapy 64 CYP#C# [001] 64 uPA 64 micafungin 64 Xelox 64 mTOR inhibitor 64 tumor necrosis 64 cathepsin B 64 sphingosine 1 64 Fingolimod 64 Dapagliflozin 64 intratumoral injection 64 mutated p# 64 pharmacokinetic interactions 64 microRNA miR 64 estrogen receptor beta 64 miglustat 64 differentiated thyroid 64 downstream effector 64 refractory metastatic 64 Vpu 64 PECAM 1 64 isoenzymes 64 VEGFR2 64 serotonin receptor 64 siRNA knockdown 64 UPLYSO 64 pDC 64 TNF Tumor Necrosis Factor 64 JAK2 64 Novel Oral 64 histone deacetylase inhibitor 64 JAK3 64 premalignant lesions 64 Sphingomab 64 histologically 64 sPLA2 64 chemo immunotherapy 64 embryonal carcinoma 64 Mcl 1 64 SGLT2 64 factor HGF 64 DAVANAT 64 SGLT2 inhibitors 64 sitaxsentan 64 TroVax ® 64 Cytotoxicity 64 Lymphocyte 64 chronic myelogenous leukemia CML 64 untreated metastatic melanoma 64 bendamustine 64 PDGF B 64 liposomal amphotericin B 64 lumiliximab 64 systemic fungal infections 64 GPIIb IIIa 64 chronic myeloid 64 irreversible inhibitor 64 NF kB pathway 64 KIF6 gene 64 gonadotrophin releasing hormone 64 PAM4 64 Epirubicin 64 nucleoside 64 riociguat 64 polyclonal 64 cytokeratin 64 Metastatic breast cancer 64 oral kinase inhibitor 64 PIK3CA 64 mGluR 64 proteasome inhibitors 64 Seliciclib 64 ziconotide 64 nab paclitaxel 64 fibrotic disease 64 bexarotene 64 substrate specificity 64 cyclin dependent kinase 64 HepDirect prodrug 64 constitutively activated 64 RNAi therapeutic targeting 64 HSP# inhibitor 64 plasma kallikrein inhibitor 64 extramedullary 64 apoptotic pathway 64 #ß 64 mineralocorticoid 64 transthyretin 64 sarcomatoid 64 chlorambucil 64 Milatuzumab 64 AMN# [001] 64 CCR9 antagonist 64 plasminogen activator